recommend a procedure for loose skin post-tirzepatide with quick appointments. 3 months vs. 6 months on Tirzepatide With Even More Powerful GLP-1s

Some clinical trials suggest a neutral effect on arrhythmia risk, indicating that these medications neither significantly increase nor decrease the likelihood of atrial fibrillation

60 minutes, 1-on-1 with your NP a real session, not a kiosk

Furthermore, this delivery method promotes quicker uptake into the bloodstream, potentially leading to faster results compared to conventional oral tablets

In the head-to-head SURMOUNT-5 trial (NEJM 2025) tirzepatide produced larger mean body-weight reduction than semaglutide (20.2% vs 13.7% at 72 weeks), although semaglutide carries the broader cardiovascular- and kidney-outcomes dataset to date